Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Generation Bio (GBIO) EBT (2022 - 2025)

Historic EBT for Generation Bio (GBIO) over the last 4 years, with Q3 2025 value amounting to -$5.5 million.

  • Generation Bio's EBT rose 6395.22% to -$5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$62.6 million, marking a year-over-year increase of 5788.56%. This contributed to the annual value of -$131.7 million for FY2024, which is 399.33% down from last year.
  • Latest data reveals that Generation Bio reported EBT of -$5.5 million as of Q3 2025, which was up 6395.22% from -$20.9 million recorded in Q2 2025.
  • Generation Bio's 5-year EBT high stood at -$5.5 million for Q3 2025, and its period low was -$74.5 million during Q1 2024.
  • For the 4-year period, Generation Bio's EBT averaged around -$29.8 million, with its median value being -$32.0 million (2022).
  • Per our database at Business Quant, Generation Bio's EBT tumbled by 11379.28% in 2024 and then soared by 8014.25% in 2025.
  • Over the past 4 years, Generation Bio's EBT (Quarter) stood at -$34.7 million in 2022, then decreased by 10.76% to -$38.4 million in 2023, then skyrocketed by 44.35% to -$21.4 million in 2024, then surged by 74.18% to -$5.5 million in 2025.
  • Its EBT stands at -$5.5 million for Q3 2025, versus -$20.9 million for Q2 2025 and -$14.8 million for Q1 2025.